Pozzoli S, Simonini M, Manunta P. Predicting AKI: Current status and future challenges. J Nephrol 2018;31(2):209–223. DOI: 10.1007/s40620-017-0416-8.
Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, et al. NGAL as a biomarker for AKI after cardiac surgery. Lancet 2005;365(9466):1231–1238. DOI: 10.1016/S0140-6736(05)74811-X.
Zhang A, Cai Y, Wang PF, Qu JN, Luo ZC, Chen D, et al. Diagnosis and prognosis of NGAL for acute kidney injury with sepsis: a systematic review and meta-analysis. Crit Care 2016;20:41. DOI: 10.1186/s13054-016-1212-x.
Tornblom S, Nisula S, Petäjä L, Vaara ST, Haapio M, Pesonen E, et al; the FINNAKI study group. Urinary NGAL as a biomarker for septic Acute Kidney Injury: a critical appraisal of clinical utility-data from the observational FINNAKI study. Ann Intensive Care 2020;10(1):51. DOI: 10.1186/s13613-020-00667-7.
Kapalavai SK, Ramachandran B, Krupanandan R, Sadasivam K. Usefulness of urinary neutrophil gelatinase-associated lipocalin as a predictor of acute kidney injury in critically ill children. Indian J Crit Care Med 2021. DOI: 10.5005/jp-journals-10071-24147.
